Halozyme Therapeutics
HALO
#2305
Rank
A$11.97 B
Marketcap
A$101.85
Share price
3.44%
Change (1 day)
35.04%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): A$1.15 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.24 Billion. In 2024 the company made an earning of A$0.84 Billion, an increase over its 2023 earnings that were of A$0.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$1.15 B37.65%
2024 A$0.84 B59.94%
2023 A$0.52 B39.94%
2022 A$0.37 B0.16%
2021 A$0.37 B92.2%
2020 A$0.19 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.13 Billion-229.51%
2017 A$93.16 M-160.48%
2016 -A$0.16 Billion216.03%
2015 -A$48.74 Million-52.86%
2014 -A$0.11 Billion-18.09%
2013 -A$0.13 Billion55.88%
2012 -A$80.99 Million169.94%
2011 -A$30.01 Million-63.44%
2010 -A$82.05 Million-7.19%
2009 -A$88.41 Million15.91%
2008 -A$76.27 Million83.89%
2007 -A$41.48 Million78.1%
2006 -A$23.29 Million16%
2005 -A$20.08 Million45.24%
2004 -A$13.83 Million682.42%
2003 -A$1.77 Million1659.12%
2002 -A$0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MannKind Corp
MNKD
A$46.55 M-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$34.02 B 2,916.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.41 Billion-136.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.92 B 1,488.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.76 B 1,119.98%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
A$48.98 B 4,242.99%๐Ÿ‡บ๐Ÿ‡ธ USA